Viewing Study NCT00040950


Ignite Creation Date: 2025-12-24 @ 5:02 PM
Ignite Modification Date: 2025-12-27 @ 11:33 AM
Study NCT ID: NCT00040950
Status: COMPLETED
Last Update Posted: 2013-12-19
First Post: 2002-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Organization Data

Organization:
Class: NIH
Study ID: CDR0000069423
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View